Ardevora Asset Management LLP Guardant Health, Inc. Transaction History

Ardevora Asset Management LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$88.71 - $120.43 $39.1 Million - $53.1 Million	-441,220 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$98.77 - $132.17 $276,556 - $370,075	2,800 Added 0.64%	441,220 $55.2 Million
Q2 2021 Jul 22, 2021	BUY	$109.77 - $165.68 $9.97 Million - $15 Million	90,798 Added 26.12%	438,420 $54.4 Million
Q1 2021 Apr 22, 2021	SELL	$127.04 - $179.1 $15.6 Million - $22 Million	-122,736 Reduced 26.09%	347,622 $53.1 Million
Q4 2020 Jan 14, 2021	BUY	$99.96 - $135.93 $47 Million - $63.9 Million	470,358 New	470,358 $60.6 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.14B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Ardevora Asset Management LLP with notifications on news.